In vivo imatinib sensitivity in a patient with GI stromal tumor bearing a PDGFRA deletion DIM842-844

J Clin Oncol. 2015 Mar 10;33(8):e41-4. doi: 10.1200/JCO.2013.50.0082. Epub 2014 Mar 17.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Benzamides / therapeutic use*
  • Biopsy
  • DNA Mutational Analysis
  • Exons
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / genetics*
  • Gene Deletion*
  • Humans
  • Imatinib Mesylate
  • Immunohistochemistry
  • Male
  • Mutation
  • Necrosis
  • Neoplasm Metastasis
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Receptor, Platelet-Derived Growth Factor alpha / genetics*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Receptor, Platelet-Derived Growth Factor alpha